CareersInvestor RelationsNews & EventsCOVID-19

Siemens Healthineers Canada

Featured products, solutions and partnerships

Meet the Atellica CI Analyzer
Neurofilament Light Chain (NfL) now available in Canada! 

Learn about our innovative new blood test for multiple sclerosis that will help predict disease activity and support earlier intervention, potentially preventing relapses in patients with Relapsing Multiple Sclerosis (RMS).

Deep Resolve
Register for the Deep Resolve Knowledge Hub

Deep dive into the usability of our deep learning reconstruction technology and clinical examples that demonstrate the excellent image quality and acquisition speed

William Osler and HHS

Tailored solutions that go beyond technology management - Value Partnerships in Canada

Across Canada, Siemens Healthineers is partnering with healthcare facilities, academic institutions, and non-profit organizations. These collaborations have helped local health systems manage their technology needs, including equipment upgrades and replacements. 

NAEOTOM Alpha 1 year Teaser

NAEOTOM Alpha® with Quantum Technology

NAEOTOM Alpha with Quantum Technology, the world's first photon-counting CT, is nothing less than the reinvention of computed tomography.

Dr. Michael Chu

Redefining the possibilities of cardiac care with an intelligent hybrid operating room. 

London Health Sciences Centre, Canada.

New epoc® NXS Host now available!

New epoc® NXS Host now available!

With the epoc® Blood Analysis System as the nexus of care, caregivers and the laboratory can stay connected to what’s important—being where patients need them most.

News and Topics

nfl

Siemens Healthineers Neurofilament Light Chain Blood Test Becomes Canada’s First to Gain Health Canada Licensing

 2024-10-21
 

Oakville, ON.

Siemens Healthineers now has a blood test for multiple sclerosis (MS) management in Canada, having received Health Canada licensing for its Neurofilament Light Chain (NfL) assay, developed with Novartis Pharma AG. The test will aid in predicting MS disease activity in patients with Relapsing Multiple Sclerosis (RMS), helping physicians manage the disease more effectively and potentially prevent relapses.

Siemens Healthineers presents mammography system with groundbreaking new imaging technology, MAMMOMAT B.brilliant, in Canada

 2024-06-24
 

OAKVILLE, Ont.

This innovative system with wide-angle tomosynthesis offers significant advancements in image quality, user ergonomics, and patient comfort level.

Siemens Healthineers announces the next generation 7T MRI scanner, MAGNETOM Terra.X, now available in Canada

 2024-04-01
 

OAKVILLE, Ont.

This cutting-edge technology, recently licensed by Health Canada, offers healthcare providers a new level of diagnostic precision, enabling them to detect even the smallest structures, anatomical details and abnormalities.

Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care

 2024-01-04
 

PALO ALTO, Calif. and HALIFAX, N.S.

Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.